FI935298A - Anvaendning av rapamycin prolaekemedel som immunosuppressiva medel - Google Patents

Anvaendning av rapamycin prolaekemedel som immunosuppressiva medel Download PDF

Info

Publication number
FI935298A
FI935298A FI935298A FI935298A FI935298A FI 935298 A FI935298 A FI 935298A FI 935298 A FI935298 A FI 935298A FI 935298 A FI935298 A FI 935298A FI 935298 A FI935298 A FI 935298A
Authority
FI
Finland
Prior art keywords
prolaekemedel
immunosuppressiva
medel
anvaendning
som
Prior art date
Application number
FI935298A
Other languages
English (en)
Other versions
FI935298A0 (fi
Inventor
Gary R Schulte
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI935298A0 publication Critical patent/FI935298A0/fi
Publication of FI935298A publication Critical patent/FI935298A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI935298A 1991-05-31 1993-11-29 Anvaendning av rapamycin prolaekemedel som immunosuppressiva medel FI935298A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70841291A 1991-05-31 1991-05-31
PCT/US1992/002504 WO1992021341A1 (en) 1991-05-31 1992-04-03 Use of rapamycin prodrugs as immunosuppressant agents

Publications (2)

Publication Number Publication Date
FI935298A0 FI935298A0 (fi) 1993-11-29
FI935298A true FI935298A (fi) 1993-11-29

Family

ID=24845706

Family Applications (1)

Application Number Title Priority Date Filing Date
FI935298A FI935298A (fi) 1991-05-31 1993-11-29 Anvaendning av rapamycin prolaekemedel som immunosuppressiva medel

Country Status (8)

Country Link
US (1) US5432183A (fi)
EP (1) EP0586512A1 (fi)
JP (1) JPH06502659A (fi)
CA (1) CA2102116A1 (fi)
FI (1) FI935298A (fi)
IE (1) IE921728A1 (fi)
PT (1) PT100556A (fi)
WO (1) WO1992021341A1 (fi)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2102116A1 (en) * 1991-05-31 1992-12-01 Gary R. Schulte Use of rapamycin prodrugs as immunosuppressant agents
ATE321053T1 (de) * 1992-10-13 2006-04-15 Wyeth Corp Carbamate von rapamycin
US5258389A (en) * 1992-11-09 1993-11-02 Merck & Co., Inc. O-aryl, O-alkyl, O-alkenyl and O-alkynylrapamycin derivatives
US5310901A (en) * 1993-03-05 1994-05-10 Merck & Co., Inc. O-heteroaryl, O-alkylheteroaryl, O-alkenylheteroaryl and O-alkynlheteroarylrapamycin derivatives
US5310903A (en) * 1993-03-05 1994-05-10 Merck & Co., Inc. Imidazolidyl rapamycin derivatives
US5504091A (en) * 1993-04-23 1996-04-02 American Home Products Corporation Biotin esters of rapamycin
CH686761A5 (de) 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
AT408520B (de) * 1993-05-27 2001-12-27 Novartis Erfind Verwalt Gmbh Galenische formulierungen
US5387680A (en) * 1993-08-10 1995-02-07 American Home Products Corporation C-22 ring stabilized rapamycin derivatives
CA2175215C (en) * 1993-11-19 2008-06-03 Yat Sun Or Semisynthetic analogs of rapamycin (macrolides) being immunomodulators
US5527907A (en) * 1993-11-19 1996-06-18 Abbott Laboratories Macrolide immunomodulators
US5780462A (en) * 1995-12-27 1998-07-14 American Home Products Corporation Water soluble rapamycin esters
US5922730A (en) * 1996-09-09 1999-07-13 American Home Products Corporation Alkylated rapamycin derivatives
EP1210350B1 (en) * 1999-08-18 2004-07-14 Wyeth Water soluble sdz-rad esters
ES2253376T3 (es) * 2000-03-29 2006-06-01 Altana Pharma Ag Profarmacos de derivados de imidazopiridina.
US6869949B2 (en) * 2000-10-25 2005-03-22 Altana Pharma Ag Polysubstituted imidazopyridines as gastric secretion inhibitors
DE60234057D1 (de) 2001-07-25 2009-11-26 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
DE60315723T2 (de) 2002-07-16 2008-06-19 Biotica Technology Ltd. Herstellung von Polyketiden und anderen natürlichen Produkten
US7160867B2 (en) * 2003-05-16 2007-01-09 Isotechnika, Inc. Rapamycin carbohydrate derivatives
US7589233B2 (en) * 2003-07-29 2009-09-15 Signature R&D Holdings, Llc L-Threonine derivatives of high therapeutic index
US8173840B2 (en) * 2003-07-29 2012-05-08 Signature R&D Holdings, Llc Compounds with high therapeutic index
CA2534342C (en) * 2003-07-29 2016-05-10 V. Ravi Chandran Amino acid prodrugs
GB0417852D0 (en) 2004-08-11 2004-09-15 Biotica Tech Ltd Production of polyketides and other natural products
US8021849B2 (en) * 2004-11-05 2011-09-20 Siemens Healthcare Diagnostics Inc. Methods and kits for the determination of sirolimus in a sample
WO2006096325A1 (en) 2005-03-07 2006-09-14 Wyeth Oxepane isomer of 42-o-(2-hydroxy)ethyl-rapamycin
GB0504994D0 (en) * 2005-03-11 2005-04-20 Biotica Tech Ltd Novel compounds
WO2006095173A2 (en) 2005-03-11 2006-09-14 Biotica Technology Limited Medical uses of 39-desmethoxyrapamycin and analogues thereof
US7189582B2 (en) * 2005-04-27 2007-03-13 Dade Behring Inc. Compositions and methods for detection of sirolimus
EP2392258B1 (en) 2005-04-28 2014-10-08 Proteus Digital Health, Inc. Pharma-informatics system
WO2007059047A2 (en) 2005-11-11 2007-05-24 Chandran V Ravi Acetylated amino acids as anti-platelet agents, nutritional and vitamin supplements
GB0609963D0 (en) * 2006-05-19 2006-06-28 Biotica Tech Ltd Novel compounds
GB0609962D0 (en) * 2006-05-19 2006-06-28 Biotica Tech Ltd Novel compounds
US8795627B2 (en) 2007-03-21 2014-08-05 Raptor Pharmaceuticals Inc. Treatment of liver disorders by administration of RAP conjugates
TW200845960A (en) * 2007-04-05 2008-12-01 Wyeth Corp Wortmannin-rapalog conjugate and uses thereof
WO2009131631A1 (en) * 2008-04-14 2009-10-29 Poniard Pharmaceuticals, Inc. Rapamycin analogs as anti-cancer agents
WO2010129819A2 (en) 2009-05-06 2010-11-11 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
GB201122305D0 (en) 2011-12-23 2012-02-01 Biotica Tech Ltd Novel compound
US20200131196A1 (en) 2017-02-10 2020-04-30 Mount Tam Therapeutics, Inc. Rapamycin Analog

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4650803A (en) * 1985-12-06 1987-03-17 University Of Kansas Prodrugs of rapamycin
US5100899A (en) * 1989-06-06 1992-03-31 Roy Calne Methods of inhibiting transplant rejection in mammals using rapamycin and derivatives and prodrugs thereof
US5200411A (en) * 1989-06-14 1993-04-06 Sandoz, Ltd. Heteroatoms-containing tricyclic compounds
GB2244991A (en) * 1990-06-11 1991-12-18 Fujisawa Pharmaceutical Co Tricyclo compounds
CA2102116A1 (en) * 1991-05-31 1992-12-01 Gary R. Schulte Use of rapamycin prodrugs as immunosuppressant agents

Also Published As

Publication number Publication date
WO1992021341A1 (en) 1992-12-10
JPH06502659A (ja) 1994-03-24
FI935298A0 (fi) 1993-11-29
PT100556A (pt) 1993-09-30
US5432183A (en) 1995-07-11
IE921728A1 (en) 1992-12-02
EP0586512A1 (en) 1994-03-16
CA2102116A1 (en) 1992-12-01

Similar Documents

Publication Publication Date Title
FI935298A (fi) Anvaendning av rapamycin prolaekemedel som immunosuppressiva medel
FI935309A0 (fi) Vattenloesliga manganpartiklar som medel foer foerstaerkande av magnetisk resonanskontrast
FI921328A (fi) Silyletrar av rapamycin
DE69332540D1 (de) Rapamycinderivate
DE69332484D1 (de) Rapamycinderivate
FI921952A (fi) Foerfarande foer framstaellning av dialkylenpiperidinofoereningar och enantiomerer daerav anvaendbara som laekemedel
FI933167A (fi) N-alkylkinuklidiniumsalter som substans-p antagonister
FI921182A (fi) Velangummi som snabbt hydratiseras
FI932369A0 (fi) Medel foer skydd av saogad traevara
DE69332582D1 (de) Rapamycinderivate
FI930722A0 (fi) Foerfarande foer framstaellning av polymerer som innehaoller ammoniumgrupper
FI922472A (fi) Gingerol- och gingerdiolderivat som hypokolesterolemiska och antiaterosklerostiska medel
FI934764A0 (fi) Anordning som hindrar krympning av kabelisolering
FI921666A (fi) Indolin- och dihydrokinolinfoereningar som oeppnare av kaliumkanal
FI923355A (fi) Vaetskeformigt hushaollstvaettmedel innehaollande insekt repellerande medel
FI923555A (fi) Foerfarande foer framstaellning av mattor som bestaor av minst tvao med varandra bundna skikt
FI931280A (fi) Medel foer maetning av bildkvalitet
FI924205A (fi) Anvaendning av 5-trans-prostaglandin f2a som oegontryck saenkande medel
FI930342A (fi) Pentapeptider som reglerar immun- och nervsystem
FI930219A0 (fi) Anvaendning av reaktionsblandningar som gjutbara massor
FI930618A (fi) Proteaser som foerorsakar onormal nedbrytning av amyloid-b-protein
FI410U1 (fi) Anordning som underlaettar grillning av koettprodukt
FIU920191U0 (fi) Foerfarande foer granskning av virkesmaetning som utfoerts av en flerfunktionsmaskin
FI922367A (fi) Foerfarande foer avskiljning av aromater fraon kolvaeteblandningar som innehaoller vilka aromater som helst
FI922368A (fi) Foerfarande foer avskiljning av aromater fraon kolvaeteblandningar som innehaoller vilka aromater som helst